Clover Health listed on the Nasdaq in January.
VIEW press/Getty Images
JPMorgan analysts have downgraded the stock of Clover Health after being underwhelmed by the healthcare company’s first-quarter earnings.
The analysts, led by Lisa Gill, cut their December…

Click here to view the original article.